EMA Application withdrawn: Jelrix — TETEC Tissue Engineering Technologies AG

View source ↗

Summary

EMA has withdrawn the Jelrix application from TETEC Tissue Engineering Technologies AG. The product targeted knee injuries and cartilage diseases, and no furthe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cartilage Diseases
• Knee Injuries

Drugs mentioned

• Jelrix

Snippet

Status: Application withdrawn. Therapeutic area: Knee Injuries;Cartilage Diseases;Knee Joint. MAH: TETEC Tissue Engineering Technologies AG. Decision date: 24/07/2025